These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

799 related items for PubMed ID: 22677793

  • 1. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV, Gross JL, Camargo JL, Zelmanovitz T, da Costa Rocha EP, Azevedo MJ.
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [Abstract] [Full Text] [Related]

  • 2. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
    Murussi M, Campagnolo N, Beck MO, Gross JL, Silveiro SP.
    Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
    [Abstract] [Full Text] [Related]

  • 3. High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.
    Sasso FC, Chiodini P, Carbonara O, De Nicola L, Conte G, Salvatore T, Nasti R, Marfella R, Gallo C, Signoriello S, Torella R, Minutolo R, Nephropathy In Type 2 Diabetes Study Group.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2269-74. PubMed ID: 22090446
    [Abstract] [Full Text] [Related]

  • 4. Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
    Kramer CK, Camargo J, Ricardo ED, Almeida FK, Canani LH, Gross JL, Azevedo MJ.
    Nephrol Dial Transplant; 2009 Apr; 24(4):1193-6. PubMed ID: 19015170
    [Abstract] [Full Text] [Related]

  • 5. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
    Tofik R, Torffvit O, Rippe B, Bakoush O.
    Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of tests for microalbuminuria screening in patients with diabetes.
    Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2402-7. PubMed ID: 16105865
    [Abstract] [Full Text] [Related]

  • 7. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality.
    Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT, PREVEND Study Group.
    Am J Epidemiol; 2008 Oct 15; 168(8):897-905. PubMed ID: 18775924
    [Abstract] [Full Text] [Related]

  • 8. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
    Herrera-Pombo JL, Aguilar-Diosdado M, Hawkins F, Campos MM, Moreno A, Garcia-Hernandez A, Castro E, García-Doncel LG, Serraclara A, Sánchez-Malo C, Escobar-Jiménez F.
    Nephron Clin Pract; 2005 Oct 15; 101(3):c116-21. PubMed ID: 16015000
    [Abstract] [Full Text] [Related]

  • 9. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes.
    Liu JJ, Tavintharan S, Yeoh LY, Sum CF, Ng XW, Pek SL, Lee SB, Tang WE, Lim SC, SMART2D study.
    Diabet Med; 2014 Oct 15; 31(10):1199-204. PubMed ID: 24702136
    [Abstract] [Full Text] [Related]

  • 10. Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension.
    Estacio RO, Dale RA, Schrier R, Krantz MJ.
    Am J Cardiol; 2012 Jun 15; 109(12):1743-8. PubMed ID: 22440125
    [Abstract] [Full Text] [Related]

  • 11. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group.
    Am J Kidney Dis; 2006 Oct 15; 48(4):571-9. PubMed ID: 16997053
    [Abstract] [Full Text] [Related]

  • 12. Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study.
    Pugliese G, Solini A, Fondelli C, Trevisan R, Vedovato M, Nicolucci A, Penno G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
    Nephrol Dial Transplant; 2011 Dec 15; 26(12):3950-4. PubMed ID: 21441399
    [Abstract] [Full Text] [Related]

  • 13. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
    Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL, Lin HD.
    Diabet Med; 2007 Dec 15; 24(12):1336-44. PubMed ID: 17941864
    [Abstract] [Full Text] [Related]

  • 14. 'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes.
    Adetunji OR, Mani H, Olujohungbe A, Abraham KA, Gill GV.
    Diabetes Res Clin Pract; 2009 Aug 15; 85(2):179-82. PubMed ID: 19481284
    [Abstract] [Full Text] [Related]

  • 15. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes.
    Canani LH, Costa LA, Crispim D, Gonçalves Dos Santos K, Roisenberg I, Lisbôa HR, Sarturi Tres G, Maia AL, Gross JL.
    Diabet Med; 2005 Sep 15; 22(9):1167-72. PubMed ID: 16108844
    [Abstract] [Full Text] [Related]

  • 16. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy.
    Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ.
    Diabetes Care; 1997 Apr 15; 20(4):516-9. PubMed ID: 9096972
    [Abstract] [Full Text] [Related]

  • 17. [Prevalence of microalbuminuria in French type 2 diabetics followed by their general practitioner].
    Marre M, Girault A, Vasmant D.
    Diabete Metab; 1995 Feb 15; 21(1):34-40. PubMed ID: 7781841
    [Abstract] [Full Text] [Related]

  • 18. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F.
    Diabetologia; 1998 Jun 15; 41(6):684-93. PubMed ID: 9662051
    [Abstract] [Full Text] [Related]

  • 19. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study.
    Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda C, Pomili B, Valentini U, Vespasiani G, De Cosmo S.
    Nutr Metab Cardiovasc Dis; 2010 Feb 15; 20(2):110-6. PubMed ID: 19447588
    [Abstract] [Full Text] [Related]

  • 20. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Hanai K, Tanaka N, Ishii A, Iwamoto Y.
    Hypertens Res; 2010 Oct 15; 33(10):1000-3. PubMed ID: 20613763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.